DB05826ExperimentalProtein Based Therapies
Prolease-r-hFSH is a recombinant human follicle stimulating hormone (r-hFSH) with Alkermes' ProLease injectable sustained release drug delivery technology. It provides patients with long term therapeutic benefit from a single administration...
- Primary indication
- Investigated for use/treatment in infertility.Curator reviewed
Which companies are running trials of Prolease-r-hFSH, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account